Smith & Nephew plc (SN) Receives Average Recommendation of “Hold” from Analysts
Smith & Nephew plc (LON:SN) has earned an average recommendation of “Hold” from the twelve research firms that are presently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, nine have issued a hold recommendation and two have assigned a buy recommendation to the company. The average 12 month target price among analysts that have covered the stock in the last year is GBX 1,288.18 ($17.09).
SN has been the topic of several recent research reports. Citigroup Inc. restated a “sell” rating and set a GBX 1,160 ($15.39) price target on shares of Smith & Nephew plc in a report on Thursday, June 22nd. HSBC Holdings plc reiterated a “hold” rating and issued a GBX 1,320 ($17.51) price objective on shares of Smith & Nephew plc in a research note on Monday, July 10th. J P Morgan Chase & Co lifted their price objective on Smith & Nephew plc from GBX 1,280 ($16.98) to GBX 1,361 ($18.05) and gave the company a “neutral” rating in a research note on Monday, July 31st. Credit Suisse Group reissued a “neutral” rating and set a GBX 1,200 ($15.92) price objective on shares of Smith & Nephew plc in a research report on Thursday, July 20th. Finally, Jefferies Group LLC boosted their price objective on Smith & Nephew plc from GBX 1,350 ($17.91) to GBX 1,515 ($20.10) and gave the stock a “buy” rating in a research report on Friday, July 28th.
In related news, insider Virginia Bottomley acquired 223 shares of Smith & Nephew plc stock in a transaction dated Wednesday, August 16th. The stock was acquired at an average price of GBX 1,380 ($18.30) per share, for a total transaction of £3,077.40 ($4,081.97).
Shares of Smith & Nephew plc (SN) opened at 1386.00 on Wednesday. The company’s market cap is GBX 12.14 billion. The company’s 50-day moving average price is GBX 1,365.42 and its 200-day moving average price is GBX 1,321.84. Smith & Nephew plc has a 12 month low of GBX 1,064.91 and a 12 month high of GBX 1,412.00.
The business also recently declared a dividend, which will be paid on Wednesday, November 1st. Shareholders of record on Thursday, October 5th will be paid a $0.12 dividend. The ex-dividend date is Thursday, October 5th. This represents a yield of 0.72%.
COPYRIGHT VIOLATION NOTICE: This piece of content was posted by American Banking News and is the sole property of of American Banking News. If you are viewing this piece of content on another website, it was copied illegally and reposted in violation of U.S. and international trademark & copyright law. The correct version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/10/04/smith-nephew-plc-sn-receives-average-recommendation-of-hold-from-analysts.html.
Smith & Nephew plc Company Profile
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.
Receive News & Ratings for Smith & Nephew plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew plc and related companies with MarketBeat.com's FREE daily email newsletter.